In January 2023, SAMHSA announced that clinicians no longer need a federal waiver to prescribe buprenorphine for treating opioid use disorder. However, clinicians are still required to register with the Drug Enforcement Agency to prescribe …
Year: 2023
New Research Publications Highlight NIATx Versatility
Recent projects have used the NIATx approach to explore coaching, how patients use mobile health apps, and how to recruit prescribers for medications for opioid use disorder (MOUD). Coaching as an implementation strategy What makes …